Medicus Sciences Acquisition closed its IPO of 9.2 million units, which included the full exercise of the underwriter’s over-allotment option to purchase 1.2 million units, at a price to the public of $10 each.
Units trade on the Nasdaq under MSACU. Each consists of one Class A ordinary share, one-ninth of one redeemable warrant, and a contingent right to receive, in certain circumstances, at least two-ninths of one redeemable warrant following an initial business combination. Once the securities comprising the units begin trading separately, shares and warrants are expected to trade under MSAC and MSACW, respectively.
Medicus will focus on the healthcare industry, particularly the medical technology sector, both in the United States and internationally. Read more.
